<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d368">
    <sentence id="DDI-DrugBank.d368.s0" text="DIAMOX modifies phenytoin metabolism with increased serum levels of phenytoin.">
        <entity id="DDI-DrugBank.d368.s0.e0" charOffset="0-5"
            type="brand" text="DIAMOX"/>
        <entity id="DDI-DrugBank.d368.s0.e1" charOffset="16-24"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d368.s0.e2" charOffset="68-76"
            type="drug" text="phenytoin"/>
        <ddi id="DDI-DrugBank.d368.s0.d0" e1="DDI-DrugBank.d368.s0.e0"
            e2="DDI-DrugBank.d368.s0.e1" type="mechanism"/>
        <ddi id="DDI-DrugBank.d368.s0.d1" e1="DDI-DrugBank.d368.s0.e0"
            e2="DDI-DrugBank.d368.s0.e2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s1" text="This may increase or enhance the occurrence of osteomalacia in some patients receiving chronic phenytoin therapy.">
        <entity id="DDI-DrugBank.d368.s1.e0" charOffset="95-103"
            type="drug" text="phenytoin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s2" text="Caution is advised in patients receiving chronic concomitant therapy."/>
    <sentence id="DDI-DrugBank.d368.s3" text="By decreasing the gastrointestinal absorption of primidone, DIAMOX may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect.">
        <entity id="DDI-DrugBank.d368.s3.e0" charOffset="49-57"
            type="drug" text="primidone"/>
        <entity id="DDI-DrugBank.d368.s3.e1" charOffset="60-65"
            type="brand" text="DIAMOX"/>
        <entity id="DDI-DrugBank.d368.s3.e2" charOffset="104-112"
            type="drug" text="primidone"/>
        <ddi id="DDI-DrugBank.d368.s3.d0" e1="DDI-DrugBank.d368.s3.e1"
            e2="DDI-DrugBank.d368.s3.e2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s4" text="Caution is advised when beginning, discontinuing, or changing the dose of DIAMOX in patients receiving primidone.">
        <entity id="DDI-DrugBank.d368.s4.e0" charOffset="74-79"
            type="brand" text="DIAMOX"/>
        <entity id="DDI-DrugBank.d368.s4.e1" charOffset="103-111"
            type="drug" text="primidone"/>
        <ddi id="DDI-DrugBank.d368.s4.d0" e1="DDI-DrugBank.d368.s4.e0"
            e2="DDI-DrugBank.d368.s4.e1" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s5" text="Because of possible additive effects with other carbonic anhydrase inhibitors, concomitant use is not advisable.">
        <entity id="DDI-DrugBank.d368.s5.e0" charOffset="48-76"
            type="group" text="carbonic anhydrase inhibitors"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s6" text="Acetazolamide may increase the effects of other folic acid antagonists.">
        <entity id="DDI-DrugBank.d368.s6.e0" charOffset="0-12"
            type="drug" text="Acetazolamide"/>
        <entity id="DDI-DrugBank.d368.s6.e1" charOffset="48-69"
            type="group" text="folic acid antagonists"/>
        <ddi id="DDI-DrugBank.d368.s6.d0" e1="DDI-DrugBank.d368.s6.e0"
            e2="DDI-DrugBank.d368.s6.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s7" text="Acetazolamide may increase or decrease blood glucose levels.">
        <entity id="DDI-DrugBank.d368.s7.e0" charOffset="0-12"
            type="drug" text="Acetazolamide"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s8" text="Consideration should be taken in patients being treated with antidiabetic agents.">
        <entity id="DDI-DrugBank.d368.s8.e0" charOffset="61-72"
            type="drug" text="antidiabetic"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s9" text="Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect.">
        <entity id="DDI-DrugBank.d368.s9.e0" charOffset="0-12"
            type="drug" text="Acetazolamide"/>
        <entity id="DDI-DrugBank.d368.s9.e1" charOffset="45-55"
            type="drug" text="amphetamine"/>
        <ddi id="DDI-DrugBank.d368.s9.d0" e1="DDI-DrugBank.d368.s9.e0"
            e2="DDI-DrugBank.d368.s9.e1" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s10" text="Acetazolamide reduces urinary excretion of quinidine and may enhance its effect.">
        <entity id="DDI-DrugBank.d368.s10.e0" charOffset="0-12"
            type="drug" text="Acetazolamide"/>
        <entity id="DDI-DrugBank.d368.s10.e1" charOffset="43-51"
            type="drug" text="quinidine"/>
        <ddi id="DDI-DrugBank.d368.s10.d0" e1="DDI-DrugBank.d368.s10.e0"
            e2="DDI-DrugBank.d368.s10.e1" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s11" text="Acetazolamide may prevent the urinary antiseptic effect of methenamine.">
        <entity id="DDI-DrugBank.d368.s11.e0" charOffset="0-12"
            type="drug" text="Acetazolamide"/>
        <entity id="DDI-DrugBank.d368.s11.e1" charOffset="59-69"
            type="drug" text="methenamine"/>
        <ddi id="DDI-DrugBank.d368.s11.d0" e1="DDI-DrugBank.d368.s11.e0"
            e2="DDI-DrugBank.d368.s11.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s12" text="Acetazolamide increases lithium excretion and the lithium may be decreased.">
        <entity id="DDI-DrugBank.d368.s12.e0" charOffset="0-12"
            type="drug" text="Acetazolamide"/>
        <entity id="DDI-DrugBank.d368.s12.e1" charOffset="24-30"
            type="drug" text="lithium"/>
        <entity id="DDI-DrugBank.d368.s12.e2" charOffset="50-56"
            type="drug" text="lithium"/>
        <ddi id="DDI-DrugBank.d368.s12.d0" e1="DDI-DrugBank.d368.s12.e0"
            e2="DDI-DrugBank.d368.s12.e1" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s13" text="Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.">
        <entity id="DDI-DrugBank.d368.s13.e0" charOffset="0-12"
            type="drug" text="Acetazolamide"/>
        <entity id="DDI-DrugBank.d368.s13.e1" charOffset="18-35"
            type="drug" text="sodium bicarbonate"/>
        <ddi id="DDI-DrugBank.d368.s13.d0" e1="DDI-DrugBank.d368.s13.e0"
            e2="DDI-DrugBank.d368.s13.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d368.s14" text="Acetazolamide may elevate cyclosporine levels.">
        <entity id="DDI-DrugBank.d368.s14.e0" charOffset="0-12"
            type="drug" text="Acetazolamide"/>
        <entity id="DDI-DrugBank.d368.s14.e1" charOffset="26-37"
            type="drug" text="cyclosporine"/>
        <ddi id="DDI-DrugBank.d368.s14.d0" e1="DDI-DrugBank.d368.s14.e0"
            e2="DDI-DrugBank.d368.s14.e1" type="mechanism"/>
    </sentence>
</document>
